Cargando…
Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non- to low-responders and B cell deficient rheumatic disease patients
OBJECTIVE: To determine whether repeated, dose-intensified mRNA vaccinations against COVID-19 increase humoral immunity in previously low-responding patients with autoimmune rheumatic diseases (AIRD), including rituximab-treated and B cell depleted patients. METHODS: Of 308 AIRD patients receiving b...
Autores principales: | ten Hagen, Alexander, Hermann, Sandra, Habermann, Elisa, Frommert, Leonie Maria, Arumahandi de Silva, Amanthi Nadira, Scholz, Veronika, Ghannam, Khetam, Klotsche, Jens, Zernicke, Jan, Alexander, Tobias, Burmester, Gerd-R., Albach, Fredrik N., Biesen, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826996/ https://www.ncbi.nlm.nih.gov/pubmed/36642057 http://dx.doi.org/10.1016/j.jaut.2023.102996 |
Ejemplares similares
-
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases
por: Arumahandi de Silva, Amanthi Nadira, et al.
Publicado: (2022) -
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease
por: Frommert, Leonie Maria, et al.
Publicado: (2022) -
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination
por: Habermann, Elisa, et al.
Publicado: (2022) -
Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series
por: ten Hagen, Alexander, et al.
Publicado: (2022) -
Performance of commercial SARS-CoV-2 wild-type and Omicron BA.1 antibody assays compared with pseudovirus neutralization tests
por: Habermann, E., et al.
Publicado: (2023)